Validation of a rapid, saliva-based, and ultra-sensitive SARS-CoV-2 screening system for a pandemic-scale infection surveillance
View ORCID ProfileRobert E Dewhurst, View ORCID ProfileTatjana Heinrich, Paul Watt, Paul Ostergaard, Jose Maria Marimon, Mariana Moreira, Philip E Houldsworth, Jack D Rudrum, David Wood, View ORCID ProfileSulev Kõks
doi: https://doi.org/10.1101/2021.11.04.21265951
Robert E Dewhurst
1Perron Institute for Neurological and Translational Science; Perth, 6009, Western Australia, Australia
2Avicena Systems Ltd, West Perth, 6005, Western Australia
Tatjana Heinrich
1Perron Institute for Neurological and Translational Science; Perth, 6009, Western Australia, Australia
2Avicena Systems Ltd, West Perth, 6005, Western Australia
Paul Watt
2Avicena Systems Ltd, West Perth, 6005, Western Australia
3Telethon Kids Institute, University of Western Australia, Perth, 6009, Western Australia
Paul Ostergaard
2Avicena Systems Ltd, West Perth, 6005, Western Australia
Jose Maria Marimon
4Biodonostia Health Research Institute, Infectious Diseases Area, Osakidetza Basque Health Service, Donostialdea Integrated Health Organization, San Sebastián, Spain
Mariana Moreira
5Lancs Lamp Laboratory, Heatley House, Bowran Street, Preston, PR1 2UX, United Kingdom
Philip E Houldsworth
5Lancs Lamp Laboratory, Heatley House, Bowran Street, Preston, PR1 2UX, United Kingdom
Jack D Rudrum
1Perron Institute for Neurological and Translational Science; Perth, 6009, Western Australia, Australia
2Avicena Systems Ltd, West Perth, 6005, Western Australia
David Wood
6University of Western Australia; Perth, 6009, Western Australia
Sulev Kõks
1Perron Institute for Neurological and Translational Science; Perth, 6009, Western Australia, Australia
7Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, 6150, Western Australia
8Prion Ltd, Tartu, 50410, Estonia
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted February 21, 2022.
Validation of a rapid, saliva-based, and ultra-sensitive SARS-CoV-2 screening system for a pandemic-scale infection surveillance
Robert E Dewhurst, Tatjana Heinrich, Paul Watt, Paul Ostergaard, Jose Maria Marimon, Mariana Moreira, Philip E Houldsworth, Jack D Rudrum, David Wood, Sulev Kõks
medRxiv 2021.11.04.21265951; doi: https://doi.org/10.1101/2021.11.04.21265951
Validation of a rapid, saliva-based, and ultra-sensitive SARS-CoV-2 screening system for a pandemic-scale infection surveillance
Robert E Dewhurst, Tatjana Heinrich, Paul Watt, Paul Ostergaard, Jose Maria Marimon, Mariana Moreira, Philip E Houldsworth, Jack D Rudrum, David Wood, Sulev Kõks
medRxiv 2021.11.04.21265951; doi: https://doi.org/10.1101/2021.11.04.21265951
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (624)
- Anesthesia (162)
- Cardiovascular Medicine (2335)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11696)
- Forensic Medicine (10)
- Gastroenterology (693)
- Genetic and Genomic Medicine (3679)
- Geriatric Medicine (345)
- Health Economics (630)
- Health Informatics (2362)
- Health Policy (925)
- Hematology (339)
- HIV/AIDS (772)
- Medical Education (363)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3438)
- Nursing (194)
- Nutrition (519)
- Oncology (1800)
- Ophthalmology (533)
- Orthopedics (217)
- Otolaryngology (285)
- Pain Medicine (230)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (415)
- Public and Global Health (6084)
- Radiology and Imaging (1254)
- Respiratory Medicine (821)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (396)
- Toxicology (50)
- Transplantation (171)
- Urology (144)